Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of Fxa-Driven Platelet Activation via Protease Activated Receptor-1".
Petzold T, Dannenberg L, Thienel M, Ahlbrecht S, Mourikis P, Helten C, M'Pembele R, Achilles A, Zikeli D, Zhang Z, Lüsebrink E, Nicolai L, Saleh I, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Petzold T, et al. Among authors: gerdes n. Circ Res. 2020 May 8;126(10):e116-e117. doi: 10.1161/CIRCRESAHA.120.316905. Epub 2020 May 7. Circ Res. 2020. PMID: 32379578 No abstract available.
IL-1 family cytokines in cardiovascular disease.
Pfeiler S, Winkels H, Kelm M, Gerdes N. Pfeiler S, et al. Among authors: gerdes n. Cytokine. 2019 Oct;122:154215. doi: 10.1016/j.cyto.2017.11.009. Epub 2017 Dec 1. Cytokine. 2019. PMID: 29198612 Review.
Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1.
Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M'Pembele R, Achilles A, Trojovky K, Konsek D, Zhang Z, Regenauer R, Pircher J, Ehrlich A, Lüsebrink E, Nicolai L, Stocker TJ, Brandl R, Röschenthaler F, Strecker J, Saleh I, Spannagl M, Mayr CH, Schiller HB, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Petzold T, et al. Among authors: gerdes n. Circ Res. 2020 Feb 14;126(4):486-500. doi: 10.1161/CIRCRESAHA.119.315099. Epub 2019 Dec 20. Circ Res. 2020. PMID: 31859592
Response by Petzold et al to Letter Regarding Article, "Rivaroxaban Reduces Arterial Thrombosis by Inhibition of FXa-Driven Platelet Activation via Protease Activated Receptor-1".
Petzold T, Thienel M, Dannenberg L, Mourikis P, Helten C, Ayhan A, M'Pembele R, Achilles A, Trojovky K, Zhang Z, Regenauer R, Pircher J, Ehrlich A, Lüsebrink E, Nicolai L, Stocker TJ, Brandl R, Röschenthaler F, Strecker J, Saleh I, Spannagl M, Mayr CH, Schiller HB, Jung C, Gerdes N, Hoffmann T, Levkau B, Hohlfeld T, Zeus T, Schulz C, Kelm M, Polzin A. Petzold T, et al. Among authors: gerdes n. Circ Res. 2020 Apr 10;126(8):e54-e55. doi: 10.1161/CIRCRESAHA.120.316786. Epub 2020 Apr 9. Circ Res. 2020. PMID: 32271680 No abstract available.
Physical Fitness and Cardiovascular Risk Factors in Novel Diabetes Subgroups.
Saatmann N, Zaharia OP, Strassburger K, Pesta DH, Burkart V, Szendroedi J, Gerdes N, Kelm M, Roden M. Saatmann N, et al. Among authors: gerdes n. J Clin Endocrinol Metab. 2022 Mar 24;107(4):1127-1139. doi: 10.1210/clinem/dgab810. J Clin Endocrinol Metab. 2022. PMID: 34748634 Free PMC article.
128 results